Jun Guo Product Safety Manager at Amway (China) R&D Center once worked at PLA Academy of Military Medical Sciences(AMMS) prior to joining Amway (China), but in a session she directly shared the stage with PLA AMMS and PLA CDC researchers, in a session they chaired and moderated, and at a conference led by a senior PLA scientist.
In Shanghai, April 14–17, 2019, the 2019 Workshop on Cosmetic Risk Assessment and Regulatory Application of Non-Animal Testing Technology brought together Chinese and international toxicology experts, corporate R&D representatives, and animal welfare organizations. The event was hosted by the Society of Toxicological Alternatives & Translational Toxicology (CSOT) and the Society of Toxicity Testing and Alternative Methods (CEMS), with sponsorship from Humane Society International, L’Oréal R&I China, Mary Kay (China) Co., Ltd., and Shanghai Medicilon Inc..
The organizing committee included: Conference Chair Peng Shuangqing, Secretaries Xiaoting Qu and Yi Shuai, and members such as Jiabin Guo (co-author on PLA-affiliated research), Kate Willett, and multiple other academics and industry representatives. The workshop program featured plenary lectures and focused sessions led by international and Chinese experts:
Gerald Renner (Cosmetic Europe) on EU regulatory implementation;
Kate Willett (Humane Society International) on non-animal safety assessment and OECD Adverse Outcome Pathway programs;
Vera Rogiers (Vrije Universiteit Brussel / EU SCCS) on in vitro toxicology and cosmetic risk assessment;
James Wakefield (Delphic HSE) on regional toxicological safety and compliance in APAC;
Lit-Hsin Loo (A*STAR, Singapore) on toxicity mode-of-action profiling;
Yuan Gao (P&G) and Jin Li (Unilever, UK) on non-animal testing integration and pathway-based risk assessment;
Taoran Xing (L’Oréal APAC) and Liping Hu (Johnson & Johnson, China) on regulatory product safety evaluation in the Asia-Pacific region.
Other key speakers at the 2019 Workshop on Cosmetic Risk Assessment and Regulatory Application of Non-Animal Testing Technology included internationally recognized experts in alternative testing and toxicology. Donna Macmillan, Principal Scientist at Lhasa Limited, leads the skin sensitization research team and promotes collaborative data-sharing to improve predictive toxicity models. Hajime Kojima, Secretary General of the Japanese Center for the Validation of Alternative Methods (JaCVAM) and Section Chief of the Division of Risk Assessment at Japan’s Biological Safety Research Center, also serves as a councilor for multiple Japanese toxicology and alternative methods societies and is an OECD expert on skin and eye irritation, sensitization, and endocrine disruptor testing. Carl Westmoreland, Director of Science & Technology at Unilever’s Safety and Environmental Assurance Centre (SEAC), focuses on delivering consumer safety without animal testing and is a member of the European Scientific Advisory Committee for ECVAM. Nathalie Alépée of L’Oréal R&I France has over twenty years of leadership in investigative toxicology, contributing to EU alternative testing projects, ESAC, and OECD regulatory guidance.
